Your browser doesn't support javascript.
loading
Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
Yuan, Shunzong; Wang, Yanqing; Luo, Hui; Jiang, Zheng; Qiao, Bing; Jiang, Yan; Hu, Yaning; Cheng, Yang; Chen, Xilin; Gong, Weihua; Huang, Yong; Zhao, Weipeng; Luo, Deyan; Liu, Bing; Su, Hang; Zhou, Jianfeng; Song, Shiping.
Afiliación
  • Yuan S; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Wang Y; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Luo H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Jiang Z; Laboratory of Oncology, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Qiao B; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Jiang Y; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Hu Y; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Cheng Y; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Chen X; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Gong W; Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Huang Y; Department of Pathology, The PLA 81st Group Army Hospital, Zhangjiakou, China.
  • Zhao W; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Luo D; Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Liu B; Laboratory of Oncology, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Su H; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
  • Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Song S; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Br J Haematol ; 189(1): 72-83, 2020 04.
Article en En | MEDLINE | ID: mdl-31960419
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Complemento / Biomarcadores de Tumor / Linfohistiocitosis Hemofagocítica / Linfoma / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Complemento / Biomarcadores de Tumor / Linfohistiocitosis Hemofagocítica / Linfoma / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: China